Trial Identifier: | MB102-091 |
Sponsor: | AstraZeneca |
Collaborator: |
Bristol-Myers Squibb
|
NCTID:: | NCT01525238 |
Start Date: | July 2012 |
Primary Completion Date: | September 2014 |
Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44150 |
Mexico, Nuevo Leon | Monterrey, Nuevo Leon, Mexico, 64460 |
Mexico, Veracruz | Veracruz, Mexico, 91910 |
USA, AL | Birmingham, AL, USA, 35233 |
USA, CA | Los Angeles, CA, USA, 90036 |
USA, FL | Orlando, FL, USA, 32827 |
USA, GA | Atlanta, GA, USA, 30322 |
USA, KY | Louisville, KY, USA, 40202 |
USA, LA | Shreveport, LA, USA, 71103 |
USA, MO | Kansas City, MO, USA, 64108 |
USA, NY | Buffalo, NY, USA, 14222 |
USA, OH | Toledo, OH, USA, 43606 |
USA, OH | Toledo, OH, USA, 43608 |
USA, PA | Philadelphia, PA, USA, 19104 |
USA, PA | Pittsburgh, PA, USA, 15224 |
USA, TN | Memphis, TN, USA, 38103 |
USA, TX | San Antonio, TX, USA, 78207 |